An independent reference library on stem cell therapy and cancer immunotherapy research.
436 articles · 2 topics · 324 Stem Cell Research · 112 Cancer Immunotherapy
Step 1 — Topic
Step 2 — Category
All 436 articles
3D bioprinting layers living cells and supportive gels to build tissue. Learn how stem cells fit into the process, what labs have shown, and what remains unsolved.
Some stem cell businesses charge patients to enroll in registered "studies." Learn what bioethics research found, how legitimate trial charges work, and the questions to ask.
South Korea approved the world's first allogeneic MSC drug and then widened access to regenerative treatments. Here's what's proven, what's marketed, and how oversight is changing.
"Legal to sell" and "proven by rigorous trials" are different questions, and the gap varies enormously by country. Here's how approval actually works across borders.
The ninth European CAR T-cell Meeting runs February 4–6, 2027, in Lisbon. Here's what the dedicated CAR-T conference covers, who attends, and why it matters.
A gene-enhanced cell therapy trial showed promising early PAH signals, but no stem cell therapy is approved and drugs and lung transplant remain standard care.
A map of reproductive conditions where stem cell research is credible, such as thin endometrium and azoospermia, versus areas still preclinical or speculative.
Blood sugar control, alcohol intake, B12 status, smoking and exercise all measurably affect peripheral nerve health as you age. Here is what the evidence supports.
GVHD is a serious complication of donor stem cell transplants. Learn its acute and chronic forms, standard treatment, and two FDA-approved cell therapies.
The FDA approved atezolizumab plus chemotherapy after surgery for stage III dMMR colon cancer, nearly halving the risk of recurrence or death in the ATOMIC trial.
Keystone Symposia's February 2027 Monaco meeting gathers cell therapy researchers on engineering, manufacturing, biomaterials and clinical translation.
Most transplants now use stem cells collected from blood. Mobilization drugs like G-CSF and plerixafor make that possible, with real but manageable risks.
Every feature article on regenmedreview carries a Sources block listing its references. Where the original source material included no external citations, that is stated explicitly rather than left blank.